{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:08:19Z","timestamp":1780452499077,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,17]]},"DOI":"10.7759\/cureus.86224","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T16:34:25Z","timestamp":1750178065000},"source":"Crossref","is-referenced-by-count":1,"title":["Insights Into the Pathophysiology of Catecholamine-Refractory Shock: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Ana","family":"Gon\u00e7alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Gon\u00e7alves Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Gon\u00e7alves Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent JL","year":"2013","unstructured":"Vincent JL, De Backer D. Circulatory shock. N Engl J Med. 2013, 369:1726-34. 10.1056\/NEJMra1208943","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2022.05.001","article-title":"Alternatives to norepinephrine in septic shock: which agents and when?","volume":"2","author":"Jozwiak M","year":"2022","unstructured":"Jozwiak M. Alternatives to norepinephrine in septic shock: which agents and when?. J Intensive Med. 2022, 2:223-32. 10.1016\/j.jointm.2022.05.001","journal-title":"J Intensive Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2023.154258","article-title":"Refractory septic shock and alternative wordings: a systematic review of literature","volume":"75","author":"Antonucci E","year":"2023","unstructured":"Antonucci E, Polo T, Giovini M, et al.. Refractory septic shock and alternative wordings: a systematic review of literature. J Crit Care. 2023, 75:154258. 10.1016\/j.jcrc.2023.154258","journal-title":"J Crit Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.accpm.2023.101193","article-title":"Multimodal strategy to counteract vasodilation in septic shock","volume":"42","author":"Leone M","year":"2023","unstructured":"Leone M, Einav S, Antonucci E, et al.. Multimodal strategy to counteract vasodilation in septic shock. Anaesth Crit Care Pain Med. 2023, 42:101193. 10.1016\/j.accpm.2023.101193","journal-title":"Anaesth Crit Care Pain Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05212-7","article-title":"Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials","volume":"28","author":"Kotani Y","year":"2024","unstructured":"Kotani Y, Belletti A, D'Amico F, et al.. Non-adrenergic vasopressors for vasodilatory shock or perioperative vasoplegia: a meta-analysis of randomized controlled trials. Crit Care. 2024, 28:439. 10.1186\/s13054-024-05212-7","journal-title":"Crit Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123192","article-title":"Lactate: the fallacy of oversimplification","volume":"11","author":"M\u00fcller J","year":"2023","unstructured":"M\u00fcller J, Radej J, Horak J, Karvunidis T, Valesova L, Kriz M, Matejovic M. Lactate: the fallacy of oversimplification. Biomedicines. 2023, 11:3192. 10.3390\/biomedicines11123192","journal-title":"Biomedicines"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14728","article-title":"Quantifying H+ exchange from muscle cytosolic energy catabolism using metabolite flux and H+ coefficients from multiple competitive cation binding: new evidence for consideration in established theories","volume":"9","author":"Robergs RA","year":"2021","unstructured":"Robergs RA. Quantifying H+ exchange from muscle cytosolic energy catabolism using metabolite flux and H+ coefficients from multiple competitive cation binding: new evidence for consideration in established theories. Physiol Rep. 2021, 9:e14728. 10.14814\/phy2.14728","journal-title":"Physiol Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X15666181212125024","article-title":"Shock - classification and pathophysiological principles of therapeutics","volume":"15","author":"Kislitsina ON","year":"2019","unstructured":"Kislitsina ON, Rich JD, Wilcox JE, et al.. Shock - classification and pathophysiological principles of therapeutics. Curr Cardiol Rev. 2019, 15:102-13. 10.2174\/1573403X15666181212125024","journal-title":"Curr Cardiol Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2017.08.009","article-title":"Cardiogenic shock","volume":"36","author":"Tewelde SZ","year":"2018","unstructured":"Tewelde SZ, Liu SS, Winters ME. Cardiogenic shock. Cardiol Clin. 2018, 36:53-61. 10.1016\/j.ccl.2017.08.009","journal-title":"Cardiol Clin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2017.1252673","article-title":"Optimum treatment of vasopressor-dependent distributive shock","volume":"15","author":"Vincent JL","year":"2017","unstructured":"Vincent JL, Leone M. Optimum treatment of vasopressor-dependent distributive shock. Expert Rev Anti Infect Ther. 2017, 15:5-10. 10.1080\/14787210.2017.1252673","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-015-0031-9","article-title":"[Obstructive shock]","volume":"64","author":"Pich H","year":"2015","unstructured":"Pich H, Heller AR. [Obstructive shock]. Anaesthesist. 2015, 64:403-19. 10.1007\/s00101-015-0031-9","journal-title":"Anaesthesist"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1212321","article-title":"Microcirculation-guided resuscitation in sepsis: the next frontier?","volume":"10","author":"Damiani E","year":"2023","unstructured":"Damiani E, Carsetti A, Casarotta E, Domizi R, Scorcella C, Donati A, Adrario E. Microcirculation-guided resuscitation in sepsis: the next frontier?. Front Med (Lausanne). 2023, 10:1212321. 10.3389\/fmed.2023.1212321","journal-title":"Front Med (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer JC","year":"2018","unstructured":"Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB. Management of refractory vasodilatory shock. Chest. 2018, 154:416-26. 10.1016\/j.chest.2017.12.021","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future","volume":"22","author":"Levy B","year":"2018","unstructured":"Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care. 2018, 22:52. 10.1186\/s13054-018-1967-3","journal-title":"Crit Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0000000000000957","article-title":"Septic shock: a microcirculation disease","volume":"34","author":"De Backer D","year":"2021","unstructured":"De Backer D, Ricottilli F, Ospina-Tasc\u00f3n GA. Septic shock: a microcirculation disease. Curr Opin Anaesthesiol. 2021, 34:85-91. 10.1097\/ACO.0000000000000957","journal-title":"Curr Opin Anaesthesiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.5935\/0103-507X.20130047","article-title":"Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock","volume":"25","author":"Ranzani OT","year":"2013","unstructured":"Ranzani OT, Monteiro MB, Ferreira EM, Santos SR, Machado FR, Noritomi DT. Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock. Rev Bras Ter Intensiva. 2013, 25:270-8. 10.5935\/0103-507X.20130047","journal-title":"Rev Bras Ter Intensiva"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1988.254.1.H20","article-title":"Mechanism of diminished contractile response to catecholamines during acidosis","volume":"254","author":"Marsh JD","year":"1988","unstructured":"Marsh JD, Margolis TI, Kim D. Mechanism of diminished contractile response to catecholamines during acidosis. Am J Physiol. 1988, 254:H20-7. 10.1152\/ajpheart.1988.254.1.H20","journal-title":"Am J Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(91)90202-w","article-title":"Effects of acidosis and ATP depletion on cardiac muscle electron transfer complex I","volume":"23","author":"Rouslin W","year":"1991","unstructured":"Rouslin W. Effects of acidosis and ATP depletion on cardiac muscle electron transfer complex I. J Mol Cell Cardiol. 1991, 23:1127-35. 10.1016\/0022-2828(91)90202-w","journal-title":"J Mol Cell Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6612276","article-title":"Admission serum ionized and total calcium as new predictors of mortality in patients with cardiogenic shock","volume":"2021","author":"Yu Y","year":"2021","unstructured":"Yu Y, Yu J, Yao R, Wang P, Zhang Y, Xiao J, Wang Z. Admission serum ionized and total calcium as new predictors of mortality in patients with cardiogenic shock. Biomed Res Int. 2021, 2021:6612276. 10.1155\/2021\/6612276","journal-title":"Biomed Res Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jointm.2024.08.003","article-title":"Parenteral calcium administration and outcomes in critically ill patients with hypocalcemia: a retrospective cohort study","volume":"5","author":"Melchers M","year":"2024","unstructured":"Melchers M, Moonen HP, Breeman TM, van Bree SH, van Zanten AR. Parenteral calcium administration and outcomes in critically ill patients with hypocalcemia: a retrospective cohort study. J Intensive Med. 2024, 5:151-9. 10.1016\/j.jointm.2024.08.003","journal-title":"J Intensive Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3022(02)00006-7","article-title":"Dynamic neuroendocrine responses to critical illness","volume":"23","author":"Van Den Berghe G","year":"2002","unstructured":"Van Den Berghe G. Dynamic neuroendocrine responses to critical illness. Front Neuroendocrinol. 2002, 23:370-91. 10.1016\/S0091-3022(02)00006-7","journal-title":"Front Neuroendocrinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1473151","article-title":"Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management","volume":"15","author":"Sobolewska J","year":"2024","unstructured":"Sobolewska J, Dzialach L, Kuca P, Witek P. Critical illness-related corticosteroid insufficiency (CIRCI) - an overview of pathogenesis, clinical presentation and management. Front Endocrinol (Lausanne). 2024, 15:1473151. 10.3389\/fendo.2024.1473151","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07374-y","article-title":"Knowing the ropes of vasopressor dosing: a focus on norepinephrine","volume":"50","author":"Kattan E","year":"2024","unstructured":"Kattan E, Ibarra-Estrada M, Jung C. Knowing the ropes of vasopressor dosing: a focus on norepinephrine. Intensive Care Med. 2024, 50:587-9. 10.1007\/s00134-024-07374-y","journal-title":"Intensive Care Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre WF","year":"2018","unstructured":"McIntyre WF, Um KJ, Alhazzani W, et al.. Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis. JAMA. 2018, 319:1889-900. 10.1001\/jama.2018.4528","journal-title":"JAMA"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2024.155004","article-title":"Early high-dose vasopressors in refractory septic shock: a cohort study","volume":"86","author":"Thompson HA","year":"2025","unstructured":"Thompson HA, Brinkman HM, Kashani KB, Cole KC, Wittwer ED, Wieruszewski PM. Early high-dose vasopressors in refractory septic shock: a cohort study. J Crit Care. 2025, 86:155004. 10.1016\/j.jcrc.2024.155004","journal-title":"J Crit Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2009.2730","article-title":"Mitochondrial regulation of cell survival and death during low-oxygen conditions","volume":"11","author":"Snyder CM","year":"2009","unstructured":"Snyder CM, Chandel NS. Mitochondrial regulation of cell survival and death during low-oxygen conditions. Antioxid Redox Signal. 2009, 11:2673-83. 10.1089\/ars.2009.2730","journal-title":"Antioxid Redox Signal"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4161\/viru.26907","article-title":"The role of mitochondrial dysfunction in sepsis-induced multi-organ failure","volume":"5","author":"Singer M","year":"2014","unstructured":"Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014, 5:66-72. 10.4161\/viru.26907","journal-title":"Virulence"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01151-3","article-title":"Lactate metabolism in human health and disease","volume":"7","author":"Li X","year":"2022","unstructured":"Li X, Yang Y, Zhang B, et al.. Lactate metabolism in human health and disease. Signal Transduct Target Ther. 2022, 7:305. 10.1038\/s41392-022-01151-3","journal-title":"Signal Transduct Target Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70154-2","article-title":"Stress hyperlactataemia: present understanding and controversy","volume":"2","author":"Garcia-Alvarez M","year":"2014","unstructured":"Garcia-Alvarez M, Marik P, Bellomo R. Stress hyperlactataemia: present understanding and controversy. Lancet Diabetes Endocrinol. 2014, 2:339-47. 10.1016\/S2213-8587(13)70154-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05039-2","article-title":"Guiding resuscitation in shock: base excess or lactate?","volume":"28","author":"Heldeweg ML","year":"2024","unstructured":"Heldeweg ML, Langer T, Du\u0161ka F. Guiding resuscitation in shock: base excess or lactate?. Crit Care. 2024, 28:249. 10.1186\/s13054-024-05039-2","journal-title":"Crit Care"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-022-06748-4","article-title":"Understanding base excess (BE): merits and pitfalls","volume":"48","author":"Langer T","year":"2022","unstructured":"Langer T, Brusatori S, Gattinoni L. Understanding base excess (BE): merits and pitfalls. Intensive Care Med. 2022, 48:1080-3. 10.1007\/s00134-022-06748-4","journal-title":"Intensive Care Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206125","article-title":"Admission lactate concentration, base excess, and alactic base excess predict the 28-day inward mortality in shock patients","volume":"11","author":"Smuszkiewicz P","year":"2022","unstructured":"Smuszkiewicz P, Jawie\u0144 N, Szrama J, Lubarska M, Kusza K, Guzik P. Admission lactate concentration, base excess, and alactic base excess predict the 28-day inward mortality in shock patients. J Clin Med. 2022, 11:6125. 10.3390\/jcm11206125","journal-title":"J Clin Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.615009","article-title":"Characterization of circulating IL-10-producing cells in septic shock patients: a proof of concept study","volume":"11","author":"Fabri A","year":"2021","unstructured":"Fabri A, Kandara K, Coudereau R, et al.. Characterization of circulating IL-10-producing cells in septic shock patients: a proof of concept study. Front Immunol. 2021, 11:615009. 10.3389\/fimmu.2020.615009","journal-title":"Front Immunol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13195678","article-title":"Biomarkers as predictors of mortality in sepsis and septic shock for patients admitted to emergency department: who is the winner? A prospective study","volume":"13","author":"Luka S","year":"2024","unstructured":"Luka S, Golea A, Tat RM, Lupan Mure\u0219an EM, Voicescu GT, Vesa \u0218C, Ionescu D. Biomarkers as predictors of mortality in sepsis and septic shock for patients admitted to emergency department: who is the winner? A prospective study. J Clin Med. 2024, 13:5678. 10.3390\/jcm13195678","journal-title":"J Clin Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06595-9","article-title":"Current practice and evolving concepts in septic shock resuscitation","volume":"48","author":"Bakker J","year":"2022","unstructured":"Bakker J, Kattan E, Annane D, et al.. Current practice and evolving concepts in septic shock resuscitation. Intensive Care Med. 2022, 48:148-63. 10.1007\/s00134-021-06595-9","journal-title":"Intensive Care Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans L","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021, 47:1181-247. 10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07590-6","article-title":"The use of echocardiography in the management of shock in critical care: a prospective, multi-centre, observational study","volume":"50","author":"Flower L","year":"2024","unstructured":"Flower L, Waite A, Boulton A, et al.. The use of echocardiography in the management of shock in critical care: a prospective, multi-centre, observational study. Intensive Care Med. 2024, 50:1668-80. 10.1007\/s00134-024-07590-6","journal-title":"Intensive Care Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3525-z","article-title":"Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine","volume":"40","author":"Cecconi M","year":"2014","unstructured":"Cecconi M, De Backer D, Antonelli M, et al.. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014, 40:1795-815. 10.1007\/s00134-014-3525-z","journal-title":"Intensive Care Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1710320","article-title":"Vasopressor therapy in the intensive care unit","volume":"42","author":"Russell JA","year":"2021","unstructured":"Russell JA, Gordon AC, Williams MD, Boyd JH, Walley KR, Kissoon N. Vasopressor therapy in the intensive care unit. Semin Respir Crit Care Med. 2021, 42:59-77. 10.1055\/s-0040-1710320","journal-title":"Semin Respir Crit Care Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-023-04593-5","article-title":"Evidence for a personalized early start of norepinephrine in septic shock","volume":"27","author":"Monnet X","year":"2023","unstructured":"Monnet X, Lai C, Ospina-Tascon G, De Backer D. Evidence for a personalized early start of norepinephrine in septic shock. Crit Care. 2023, 27:322. 10.1186\/s13054-023-04593-5","journal-title":"Crit Care"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2009.106","article-title":"Stress and disorders of the stress system","volume":"5","author":"Chrousos GP","year":"2009","unstructured":"Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009, 5:374-81. 10.1038\/nrendo.2009.106","journal-title":"Nat Rev Endocrinol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05801-z","article-title":"Vasopressor therapy in critically ill patients with shock","volume":"45","author":"Russell JA","year":"2019","unstructured":"Russell JA. Vasopressor therapy in critically ill patients with shock. Intensive Care Med. 2019, 45:1503-17. 10.1007\/s00134-019-05801-z","journal-title":"Intensive Care Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran M","year":"2019","unstructured":"Nagendran M, Russell JA, Walley KR, et al.. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials. Intensive Care Med. 2019, 45:844-55. 10.1007\/s00134-019-05620-2","journal-title":"Intensive Care Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005919","article-title":"Advances in the management of cardiogenic shock","volume":"51","author":"Jentzer JC","year":"2023","unstructured":"Jentzer JC, P\u00f6ss J, Schaubroeck H, Morrow DA, Hollenberg SM, Mebazaa A. Advances in the management of cardiogenic shock. Crit Care Med. 2023, 51:1222-33. 10.1097\/CCM.0000000000005919","journal-title":"Crit Care Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005317","article-title":"Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock","volume":"50","author":"Sacha GL","year":"2022","unstructured":"Sacha GL, Lam SW, Wang L, Duggal A, Reddy AJ, Bauer SR. Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock. Crit Care Med. 2022, 50:614-23. 10.1097\/CCM.0000000000005317","journal-title":"Crit Care Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7427.1332","article-title":"Adrenaline in the treatment of anaphylaxis: what is the evidence?","volume":"327","author":"McLean-Tooke AP","year":"2003","unstructured":"McLean-Tooke AP, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence?. BMJ. 2003, 327:1332-5. 10.1136\/bmj.327.7427.1332","journal-title":"BMJ"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna A","year":"2017","unstructured":"Khanna A, English SW, Wang XS, et al.. Angiotensin II for the treatment of vasodilatory shock. N Engl J Med. 2017, 377:419-30. 10.1056\/NEJMoa1704154","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-04839-w","article-title":"Administration of methylene blue in septic shock: pros and cons","volume":"28","author":"Arias-Ortiz J","year":"2024","unstructured":"Arias-Ortiz J, Vincent JL. Administration of methylene blue in septic shock: pros and cons. Crit Care. 2024, 28:46. 10.1186\/s13054-024-04839-w","journal-title":"Crit Care"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009669.pub4","article-title":"Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome","volume":"11","author":"Uhlig K","year":"2020","unstructured":"Uhlig K, Efremov L, Tongers J, Frantz S, Mikolajczyk R, Sedding D, Schumann J. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome. Cochrane Database Syst Rev. 2020, 11:CD009669. 10.1002\/14651858.CD009669.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew R","year":"2021","unstructured":"Mathew R, Di Santo P, Jung RG, et al.. Milrinone as compared with dobutamine in the treatment of cardiogenic shock. N Engl J Med. 2021, 385:516-25. 10.1056\/NEJMoa2026845","journal-title":"N Engl J Med"},{"key":"ref51","doi-asserted-by":"crossref","DOI":"10.2147\/vhrm.2006.2.4.389","article-title":"A review of levosimendan in the treatment of heart failure","volume":"2","author":"Kasikcioglu HA","year":"2006","unstructured":"Kasikcioglu HA, Cam N. A review of levosimendan in the treatment of heart failure. Vasc Health Risk Manag. 2006, 2:389-400.","journal-title":"Vasc Health Risk Manag"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2019.04.045","article-title":"The controversial role of corticosteroids in septic shock","volume":"37","author":"Pourmand A","year":"2019","unstructured":"Pourmand A, Whiteside T, Yamane D, Rashed A, Mazer-Amirshahi M. The controversial role of corticosteroids in septic shock. Am J Emerg Med. 2019, 37:1353-61. 10.1016\/j.ajem.2019.04.045","journal-title":"Am J Emerg Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1733900","article-title":"What is the role of steroids for septic shock in 2021?","volume":"42","author":"Nedel W","year":"2021","unstructured":"Nedel W, Lisboa T, Salluh JI. What is the role of steroids for septic shock in 2021?. Semin Respir Crit Care Med. 2021, 42:726-34. 10.1055\/s-0041-1733900","journal-title":"Semin Respir Crit Care Med"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.11.015","article-title":"The impact of vitamin C-containing treatment on the mortality of patients with sepsis: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Chen CY","year":"2022","unstructured":"Chen CY, Chiu CT, Lee HS, Lai CC. The impact of vitamin C-containing treatment on the mortality of patients with sepsis: a systematic review and meta-analysis of randomized controlled trials. J Infect Public Health. 2022, 15:1514-20. 10.1016\/j.jiph.2022.11.015","journal-title":"J Infect Public Health"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2017.04.039","article-title":"Experience using high-dose glucose-insulin-potassium (GIK) in critically ill patients","volume":"41","author":"Slob EM","year":"2017","unstructured":"Slob EM, Shulman R, Singer M. Experience using high-dose glucose-insulin-potassium (GIK) in critically ill patients. J Crit Care. 2017, 41:72-7. 10.1016\/j.jcrc.2017.04.039","journal-title":"J Crit Care"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1186\/cc1052","article-title":"Noradrenaline and the kidney: friends or foes?","volume":"5","author":"Bellomo R","year":"2001","unstructured":"Bellomo R, Giantomasso DD. Noradrenaline and the kidney: friends or foes?. Crit Care. 2001, 5:294-8. 10.1186\/cc1052","journal-title":"Crit Care"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.1956.tb03341.x","article-title":"The local effect on the eye of noradrenaline","volume":"34","author":"Owe-Larsson A","year":"1956","unstructured":"Owe-Larsson A. The local effect on the eye of noradrenaline. Acta Ophthalmol (Copenh). 1956, 34:27-34. 10.1111\/j.1755-3768.1956.tb03341.x","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1113\/JP281951","article-title":"The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota-gut-brain axis perspective","volume":"601","author":"Leigh SJ","year":"2023","unstructured":"Leigh SJ, Uhlig F, Wilmes L, et al.. The impact of acute and chronic stress on gastrointestinal physiology and function: a microbiota-gut-brain axis perspective. J Physiol. 2023, 601:4491-538. 10.1113\/JP281951","journal-title":"J Physiol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0339OC","article-title":"Norepinephrine dysregulates the immune response and compromises host defense during sepsis","volume":"202","author":"Stolk RF","year":"2020","unstructured":"Stolk RF, van der Pasch E, Naumann F, et al.. Norepinephrine dysregulates the immune response and compromises host defense during sepsis. Am J Respir Crit Care Med. 2020, 202:830-42. 10.1164\/rccm.202002-0339OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"26","author":"Wieruszewski PM","year":"2022","unstructured":"Wieruszewski PM, Khanna AK. Vasopressor choice and timing in vasodilatory shock. Crit Care. 2022, 26:76. 10.1186\/s13054-022-03911-7","journal-title":"Crit Care"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell JA","year":"2008","unstructured":"Russell JA, Walley KR, Singer J, et al.. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008, 358:877-87. 10.1056\/NEJMoa067373","journal-title":"N Engl J Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon AC","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, et al.. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016, 316:509-18. 10.1001\/jama.2016.10485","journal-title":"JAMA"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.3046","article-title":"Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study","volume":"333","author":"Kalimouttou A","year":"2025","unstructured":"Kalimouttou A, Kennedy JN, Feng J, et al.. Optimal vasopressin initiation in septic shock: the OVISS reinforcement learning study. JAMA. 2025, 333:1688-98. 10.1001\/jama.2025.3046","journal-title":"JAMA"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-025-01472-w","article-title":"Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study","volume":"15","author":"Melchers M","year":"2025","unstructured":"Melchers M, de Smet V, Rooijakkers C, et al.. Hemodynamic effects of adjunct arginine vasopressin to norepinephrine in septic shock: insights from a prospective multicenter registry study. Ann Intensive Care. 2025, 15:59. 10.1186\/s13613-025-01472-w","journal-title":"Ann Intensive Care"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1186\/cc11469","article-title":"Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials","volume":"16","author":"Serpa Neto A","year":"2012","unstructured":"Serpa Neto A, Nassar AP, Cardoso SO, et al.. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care. 2012, 16:R154. 10.1186\/cc11469","journal-title":"Crit Care"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s44158-024-00150-w","article-title":"Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review","volume":"4","author":"Coloretti I","year":"2024","unstructured":"Coloretti I, Genovese A, Teixeira JP, et al.. Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review. J Anesth Analg Crit Care. 2024, 4:13. 10.1186\/s44158-024-00150-w","journal-title":"J Anesth Analg Crit Care"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000001196","article-title":"Variation in corticosteroid prescribing practices for patients with septic shock","volume":"7","author":"Soni K","year":"2025","unstructured":"Soni K, Minturn JS, Davis BS, Bukowski LA, Kahn JM, Barbash IJ. Variation in corticosteroid prescribing practices for patients with septic shock. Crit Care Explor. 2025, 7:e1196. 10.1097\/CCE.0000000000001196","journal-title":"Crit Care Explor"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1177\/08850666231183396","article-title":"Sepsis and adrenal insufficiency","volume":"38","author":"Fowler C","year":"2023","unstructured":"Fowler C, Raoof N, Pastores SM. Sepsis and adrenal insufficiency. J Intensive Care Med. 2023, 38:987-96. 10.1177\/08850666231183396","journal-title":"J Intensive Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/376057-insights-into-the-pathophysiology-of-catecholamine-refractory-shock-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T16:34:26Z","timestamp":1750178066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/376057-insights-into-the-pathophysiology-of-catecholamine-refractory-shock-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":68,"URL":"https:\/\/doi.org\/10.7759\/cureus.86224","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}